Surprising results of a study comparing Moderna and Pfizer
Research at the CHUV analyzes the vaccine response induced by the two vaccines once morest the variants preceding Omicron.
The greater durability of neutralizing antibodies is explained by the vaccine dose of Moderna, which is three times more powerful than that of Pfizer.
KEYSTONE/Laurent Gillieron
CHUV scientists compared the immune response induced by mRNA vaccines once morest the original coronavirus and the Alpha, Beta, Gamma and Delta variants. We are talking here regarding the production, by the vaccinated person, of so-called “neutralizing” antibodies, namely antibodies that truly protect once morest SARS-CoV-2 infection. Moderna advantage, the post concludes.
